Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

JAK2 V617F mutation and 46/1 haplotype in Chinese Budd-Chiari syndrome patients.

Journal of gastroenterology and hepatology - 1 Jan 2014

Wang Hui, Sun Guixiang, Zhang Peijin, Zhang Jing, Gui Er, Zu Maoheng, Jia Enzhi, Xu Hao, Xu Lichun, Zhang Jinpeng, Lu Zhaojun

Abstract excerpt

BACKGROUND AND AIM: The presence of JAK2V617F was reported to be associated with JAK2 46/1 haplotype, which was considered as an independent risk factor for Budd-Chiari syndrome (BCS) in Western countries. However, little is known in China. Therefore, the aim of this study was to determine whether the 46/1 haplotype is associated with such patients. METHODS: Patients with primary BCS and controls were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asian People
Share to Budd-Chiari Syndrome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Haplotypes

Share to Janus Kinase 2

Share to Myeloproliferative Disorders

Share to Prevalence

Source

Identifiers

PMID: 23980667
DOI: 10.1111/jgh.12379

Genes

JAK2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

JAK2 V617F mutation and 46/1 haplotype in Chinese Budd-Chiari syndrome patients.PMID 23980667Read ↗

[Relationship between V617F mutation and 46/1 haplotype in JAK2 gene in patients with chronic myeloproliferative diseases and frequencies of 46/1 haplotype in different Chinese nationalities].Semantic proximity Read ↗

JAK2 46/1 haplotype is associated with JAK2 V617F--positive myeloproliferative neoplasms in Brazilian patients.Semantic proximity Read ↗

The JAK2 46/1 haplotype in Budd-Chiari syndrome and portal vein thrombosis.Semantic proximity Read ↗

JAK2 46/1 haplotype is associated with JAK2 V617F-positive myeloproliferative neoplasms in Japanese patients.Semantic proximity Read ↗

Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: a prospective study.Semantic proximity Read ↗

JAK2 46/1 (GGCC) Haplotype: A Biomarker for Oncogenesis, Risk Stratification, and Drug Resistance in Myeloproliferative NeoplasmsSemantic proximity Read ↗

Meta-analysis: the significance of screening for JAK2V617F mutation in Budd-Chiari syndrome and portal venous system thrombosis.Semantic proximity Read ↗

The G allele of the JAK2 rs10974944 SNP, part of JAK2 46/1 haplotype, is strongly associated with JAK2 V617F-positive myeloproliferative neoplasms.Semantic proximity Read ↗

The Contribution of JAK2 46/1 Haplotype in the Predisposition to Myeloproliferative Neoplasms.Semantic proximity Read ↗

JAK2V617F allele burden, JAK2 46/1 haplotype and clinical features of Chinese with myeloproliferative neoplasmsSemantic proximity Read ↗

Evaluation of the association between the JAK2 46/1 haplotype and chronic myeloproliferative neoplasms in a Brazilian population.Semantic proximity Read ↗

JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.